MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

TMO · NYSE

Thermo Fisher Scientific Inc

Industrials · Industrial Machinery/Components

Reference price$576.41As of Jul 28, 2026
Market capitalization$214B
52-week range$435.27$643.99
S&P 500 portfolio weight0.33%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$520.00-9.8% vs. reference
Average$606.76+5.3% vs. reference
High$675.00+17.1% vs. reference
13 Buy5 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportNot availableSep 2026
Consensus EPS$6.368 estimates
Expected range$6.10–$6.45Low to high EPS
Dec 2026$25.12Street EPS consensus
Dec 2027$27.46Street EPS consensus
Dec 2028$29.98Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+3.9% YoY$44.56B$42.88B
Operating income$7.75B$7.34B
Net income$6.7B$6.34B
Operating cash flow$7.82B$8.67B
Capital expenditures($1.53B)($1.4B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Evidence

Sources & method

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.